Clinicopathologic and immunohistochemical differences in complete and partial hydatidiform moles in a multiracial Malaysian population

International Journal of Gynecological Pathology

Volumn 24, Issue 3, 2005, Pages 277-285

  Hayati, Abdul Rahman ^a   Tan, Geok Chin ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; PROTEIN P57;

ADULT; ARTICLE; CELL PROLIFERATION; CHROMOSOME ABERRATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HISTOPATHOLOGY; HUMAN; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KARYOTYPE; MALAYSIA; PLACENTA; POPULATION RESEARCH; PREGNANCY DISORDER; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; TROPHOBLAST; TROPHOBLASTIC DISEASE;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; CYCLIN-DEPENDENT KINASE INHIBITOR P57; FEMALE; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MALAYSIA; MIDDLE AGED; NUCLEAR PROTEINS; PREGNANCY; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 21244476453     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000161312.30054.54     Document Type: Article

References (36)

1. Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 2001;20:31-47.
2. Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 1994;39:155-62.
3. Kim SJ, Bae SN, Kim JH, et al. Epidemiology and time trends of gestational trophoblastic disease in Korea. Int J Gynaecol Obstet 1998;60:S33-8.
4. Rosai J. Female reproductive system. In: Rosai J, ed. Ackerman's Surgical Pathology. 8th ed. St. Louis: Mosby, 1996:1540-59.
5. Robbins SL, Cotran RS, Kumar V, et al. Gestational and placental disorders. In: Cotran RS, Kumar V, Collins T, eds. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB Saunders, 1999:1079-89.
6. Clemet PB, Young RH. Trophoblastic lesions. In: Atlas of Gynecologic Surgical Pathology. Philadelphia: WB Saunders, 2000:211-6.
7. Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973-83. Lancet 1986;2:673-7.
8. Bagshawe KD, Rawlins G, Pike MC, et al. ABO blood-groups in trophoblastic neoplasia. Lancet 1971;1:553-6.
9. Berkowitz RS, Cramer DW, Berstein MR, et al. Risk factors for complete molar pregnancy from a case-control study. Am J Obstet Gynecol 1985;152:1016-20.
10. Buckley JD. The epidemiology of molar pregnancy and choriocarcinoma. Clin Obstet Gynecol 1984;27:153-9.
11. Azuma C, Saji F, Tokugawa Y, et al. Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA. The detection of anuclear empty ovum as the cause of complete mole. Gynecol Oncol 1991;40:29-33.
12. Kajii T, Ohama K. Androgenetic origin of hydatidiform mole. Nature 1977;268:633-4.
13. Mcfadden DE, Kwong LC, Yam IY, et al. Parental origin of tripoidy in human fetuses: evidence for genomic imprinting. Hum Genet 1993;92:465-9.
14. Zaragoza MV, Surti U, Redline RW, et al. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. Am J Hum Genet 2000;66:1807-20.
15. Hertig AT. Hydatidiform mole and chorionepithelioma. In Meigs JV, Sturgis SH, eds: Progress in gynecology, New York, 1950, Grune & Stratton, Inc.
16. Conran RM, Hitchcock CL, Popek EJ, et al. Diagnostic consideration in molar gestation. Hum Pathol 1993;24:41-8.
17. Messerli ML, Parmley T, Woodruff JD, et al. Inter- and intra-pathologist variability in the diagnosis of gestational trophoblastic neoplasia. Obstet Gynecol 1987;69:622-6.
18. Mosher R, Goldstein DP, Berkowitz R, et al. Complete hydatidiform mole: Comparison of clinicopathologic features, current and past. J Reprod Med 1998;43:21-7.
19. Schorge JO, Goldstein DP, Bernstein MR, et al. Recent advances in gestational trophoblastic disease. J Reprod Med 2000;45:692-700.
20. Bell KA, Van Deerlin V, Addya K, et al. Molecular genetic testing from paraffin-embedded tissue distinguishes non-molar hydropic abortion from hydatidiform mole. Mol Diagn 1999;4:11-9.
21. Fisher RA, Newlands ES. Rapid diagnosis and classification of hydatidiform mole with polymerase chain reaction. Am J Obstet Gynecol 1993;168:563-9.
22. Fox H. Differential diagnosis of hydatidiform moles. Genet Diagn Pathol 1997;143:117-25.
23. Benirschke K. Editorial. Flow cytometry for all mole-like abortion specimens. Hum Pathol 1989;20:403-4.
24. Fisher RA, Lawler SD, Ormerod MG, et al. Flow cytometry used to distinguish between complete and partial hydatidiform moles. Placenta 1987;8:249-56.
25. Lage JM, Driscoll SG, Yavner DL, et al. Hydatidiform moles. Application of flow cytometry in diagnosis. Am J Clin Pathol 1988;89:596-600.
26. Teng NN, Ballon SC. Partial hydatidiform mole with diploid karyotype: report of three cases. Am J Obstet Gynecol 1984;150:961-4.
27. Lage JM, Weinberg DS, Yavner DL, et al. The biology of tetraploid hydatidiform mole: histopathology, cytogenetics, and flow cytometry. Hum Pathol 1989;20:419-25.
28. Takagi N, Asano S-I, Fusisawa M, et al. A possible triploid/diploid case of hydatidiform mole. Chromosome Information Service 1969;10:21-2.
29. Matsuoka S, Edwards MC, Bai C. p57KIP2 a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995;9:650-62.
30. Zhang P, Liegeois NJ, Wong C, et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicate a role in Beckwith-Wiedemann syndrome. Nature 1997;387:151-8.
31. Taniguchi T, Okamoto K, Reeve AE. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour. Oncogene 1997;14:1201-6.
32. Jun SY, Ro JY, Kim KR. P57Kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Histopathology 2003;43:17-25.
33. Crisp H, Burton JL, Stewart R, et al. Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57KIP2 immunohistochemistry. Histopathology 2003;43:363-73.
34. KIP2. Am J Surg Pathol 2001;25:1225-30.
35. Chilosi M, Piazzola E, Lestani M, et al. Differential expression of p57Kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 1998;78:269-76.
36. Tan JAMA, George E, Tan KL, et al. Molecular defects in the β-globin gene identified in different ethnic groups/populations during prenatal diagnosis for β-thalassemia: a Malaysian experience. Clin Exp Med 2004;4:142-7.